Hepatocellular Carcinoma: Regional Therapy with a Magnetic Targeted Carrier Bound to Doxorubicin in a Dual MR Imaging/ Conventional Angiography Suite-Initial Experience with Four Patients

Radiology

Volumn 230, Issue 1, 2004, Pages 287-293

  Wilson, Mark W ^a   Kerlan Jr , Robert K ^a   Fidelman, Nicholas A ^a   Venook, Alan P ^b   LaBerge, Jeanne M ^a   Koda, Joy ^c   Gordon, Roy L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c FeRX Inc   (United States)

Author keywords

Liver neoplasms, angiography; Liver neoplasms, MR; Liver neoplasms, therapy; Liver, interventional procedures; Magnetic resonance (MR), guidance

Indexed keywords

ANALGESIC AGENT; DOXORUBICIN; DRUG CARRIER;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG DELIVERY SYSTEM; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; ANGIOGRAPHY; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; DOXORUBICIN; DRUG CARRIERS; EQUIPMENT DESIGN; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MALE; MIDDLE AGED;

EID: 0346218095     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2301021493     Document Type: Article

References (15)

1. Bergsland EK, Venook AP. Hepatocellular carcinoma. Curr Opin Oncol 2000; 12:357-361.
2. Geschwind JF. Chemoembolization for hepatocellular carcinoma: where does the truth lie? J Vasc Interv Radiol 2002; 13:991-994.
3. Bartolozzi C, Lencioni R, Caramella D, Mazzeo S, Ciancia EM. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging. AJR Am J Roentgenol 1994; 162:827-831.
4. Sironi S, Livraghi T, Meloni F, De Cobelli F, Ferrero CG, Del Maschio A. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 1999; 173:1225-1229.
5. Bartolozzi C, Lencioni R, Caramella D, Falaschi F, Cioni R, DiCoscio G. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection. Radiology 1994; 191:123-128.
6. Lu DSK, Sinha S, Lucas J, Farahani K, Lufkin R, Lewin K. MR-guided percutaneous ethanol ablation of liver tissue in a .2-T open MR system: preliminary study in porcine model. J Magn Reson Imaging 1997; 7:303-308.
7. Shinmoto H, Mulkern RV, Oshio K, Silverman SG, Colucci VM, Jolesz FA. MR appearance and spectral features of injected ethanol in the liver: implication for fast MR-guided percutaneous ethanol injection therapy. J Comput Assist Tomogr 1997; 21:82-88.
8. Silverman SG, Tuncali K, Adams DF, et al. MR imaging-guided percutaneous cryotherapy of liver tumors: initial experience. Radiology 2000; 217:657-664.
9. Wacker FK, Reither K, Ritz JP, Roggan A, Germer CT, Wolf KJ. MR-guided interstitial laser-induced thermotherapy of hepatic metastasis combined with arterial blood flow reduction: technique and first clinical results in an open MR system. J Magn Reson Imaging 2001; 13:31-36.
10. Koda J, Venook A, Walser E, et al. A multicenter phase I/II trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinoma. Proc Am Soc Clin Oncol Meet 2001; 20:168a.
11. Rudge S, Peterson C, Vessely C, Koda J, Stevens S, Catterall L. Adsorption and desorption of chemotherapeutic drugs from a magnetically targeted carrier (MTC). J Control Release 2001; 74:335-340.
12. Goodwin SC, Bittner CA, Peterson CL, Wong G. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. Toxicol Sci 2001; 60:177-183.
13. Kim YB, Park YN, Park C. Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization. Histopathology 2001; 38:160-166.
14. Yi J, Liao X, Yang Z, Li X. Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization. J Tongji Med Univ 2001; 21:321-322, 331.
15. Fidelman N, Wilson MW, Weber OM, et al. Real-time MR properties of particulate embolic agents tested in a dynamic flow model. J Vasc Interv Radiol 2002; 13:613-618.